Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 02, 2018 08:00 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Host Third Quarter 2018 Financial Results Conference Call on Thursday, November 8, 2018 at 4:30 p.m. ET

BASKING RIDGE, N.J., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company with multiple technology...
September 27, 2018 08:00 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Participate in Upcoming October Conferences

Company Receives “Buzz of BIO” Award at the 2018 BIO Investor Forum BASKING RIDGE, N.J., Sept. 27, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the...
August 30, 2018 08:00 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

BASKING RIDGE, N.J., Aug. 30, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple...
August 09, 2018 16:05 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences Reports 2018 Second Quarter and First Six Months Financial Results

BASKING RIDGE, N.J., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple...
August 02, 2018 08:00 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Host Second Quarter 2018 Financial Results Conference Call on Thursday, August 9, 2018 at 4:30 p.m. ET

BASKING RIDGE, N.J., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq:CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company with multiple technology...
June 19, 2018 08:00 ET | Source: Caladrius Biosciences, Inc.

Caladrius Receives FDA Regenerative Medicine Advanced Therapy Designation for CD34+ Cell Therapy for Treating Refractory Angina

BASKING RIDGE, N.J., June 19, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq:CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company with multiple technology...
June 05, 2018 08:00 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences Sells Rights to Counter-Flow Centrifugation System to Hitachi Chemical Advanced Therapeutics Solutions

BASKING RIDGE, N.J., June 05, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq:CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company with multiple technology...
May 10, 2018 16:05 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences Reports 2018 First Quarter Financial Results

BASKING RIDGE, N.J., May 10, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq:CLBS) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology...
May 07, 2018 08:00 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Participate at the 15th International Symposium on Cardiovascular Regeneration and Repair

BASKING RIDGE, N.J. , May 07, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq:CLBS) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple...
May 03, 2018 08:00 ET | Source: Caladrius Biosciences, Inc.

Caladrius Biosciences to Host First Quarter 2018 Financial Results Conference Call on Thursday, May 10, 2018 at 4:30 p.m. Eastern Time

BASKING RIDGE, N.J., May 03, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq:CLBS) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology...